440 related articles for article (PubMed ID: 27496774)
1. Multivalent Chromosomal Expression of the Clostridium botulinum Serotype A Neurotoxin Heavy-Chain Antigen and the Bacillus anthracis Protective Antigen in Lactobacillus acidophilus.
O'Flaherty S; Klaenhammer TR
Appl Environ Microbiol; 2016 Oct; 82(20):6091-6101. PubMed ID: 27496774
[TBL] [Abstract][Full Text] [Related]
2. Directed chromosomal integration and expression of the reporter gene gusA3 in Lactobacillus acidophilus NCFM.
Douglas GL; Klaenhammer TR
Appl Environ Microbiol; 2011 Oct; 77(20):7365-71. PubMed ID: 21873486
[TBL] [Abstract][Full Text] [Related]
3. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
Sahay B; Colliou N; Zadeh M; Ge Y; Gong M; Owen JL; Valletti M; Jobin C; Mohamadzadeh M
Vaccine; 2018 Jan; 36(1):155-164. PubMed ID: 29180028
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge.
Mohamadzadeh M; Duong T; Sandwick SJ; Hoover T; Klaenhammer TR
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4331-6. PubMed ID: 19246373
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification and characterization of the receptor-binding domain of botulinum neurotoxin serotype B as a vaccine candidate.
Ben David A; Torgeman A; Barnea A; Zichel R
Protein Expr Purif; 2015 Jun; 110():122-9. PubMed ID: 25727047
[TBL] [Abstract][Full Text] [Related]
6. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
[TBL] [Abstract][Full Text] [Related]
7. Integrative food grade expression system for lactic acid bacteria.
Douglas GL; Goh YJ; Klaenhammer TR
Methods Mol Biol; 2011; 765():373-87. PubMed ID: 21815104
[TBL] [Abstract][Full Text] [Related]
8. Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines.
Gat O; Inbar I; Aloni-Grinstein R; Zahavy E; Kronman C; Mendelson I; Cohen S; Velan B; Shafferman A
Infect Immun; 2003 Feb; 71(2):801-13. PubMed ID: 12540560
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity.
Kalb SR; Boyer AE; Barr JR
Toxins (Basel); 2015 Aug; 7(9):3497-511. PubMed ID: 26404376
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.
Yu YZ; Zhang SM; Sun ZW; Wang S; Yu WY
Vaccine; 2007 Dec; 25(52):8843-50. PubMed ID: 18022294
[TBL] [Abstract][Full Text] [Related]
12. Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.
Liu FJ; Shi DY; Mao YY; Xiong XH; Lu JS; Pang XB; Dong XJ; Yang ZX; Yu YZ
Vaccine; 2020 Mar; 38(14):2978-2983. PubMed ID: 32113807
[TBL] [Abstract][Full Text] [Related]
13. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains.
Hill KK; Xie G; Foley BT; Smith TJ; Munk AC; Bruce D; Smith LA; Brettin TS; Detter JC
BMC Biol; 2009 Oct; 7():66. PubMed ID: 19804621
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the functional activity of botulinum neurotoxin subtype B6.
Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
[TBL] [Abstract][Full Text] [Related]
15. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
[TBL] [Abstract][Full Text] [Related]
16. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
Kull S; Schulz KM; Weisemann J; Kirchner S; Schreiber T; Bollenbach A; Dabrowski PW; Nitsche A; Kalb SR; Dorner MB; Barr JR; Rummel A; Dorner BG
PLoS One; 2015; 10(2):e0116381. PubMed ID: 25658638
[TBL] [Abstract][Full Text] [Related]
17. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
Davies JR; Rees J; Liu SM; Acharya KR
J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
[TBL] [Abstract][Full Text] [Related]
18. A multipathogen DNA vaccine elicits protective immune responses against two class A bioterrorism agents, anthrax and botulism.
Kim NY; Son WR; Lee MH; Choi HS; Choi JY; Song YJ; Yu CH; Song DH; Hur GH; Jeong ST; Hong SY; Shin YK; Shin S
Appl Microbiol Biotechnol; 2022 Feb; 106(4):1531-1542. PubMed ID: 35141866
[TBL] [Abstract][Full Text] [Related]
19. Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5.
Dover N; Barash JR; Hill KK; Davenport KW; Teshima H; Xie G; Arnon SS
PLoS One; 2013; 8(4):e61205. PubMed ID: 23637798
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant.
Li N; Yu YZ; Yu WY; Sun ZW
Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):211-9. PubMed ID: 21284488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
